Skip to content

KORU Medical Systems KRMD Intangible Purchases

Intangible Purchases at other companies

ICU Medical logo
ICU MedicalICUI
$1.91M-14.5%
AptarGroup logo
AptarGroupATR
$592K-76.1%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$757K+65.6%
iRadimed logo
iRadimedIRMD
$66K-70.0%

Other financials

Income statement

See full
Revenue$11.8M+22.1%
Gross profit$7.2M+19.6%
Operating income-$864.9K+30.5%
Net income-$807.1K+30.8%
EPS (diluted)-$0.02+33.3%

Balance sheet

See full
Cash & equivalents$8.8M+0.4%
Total debt$3.5M-2.8%
Total equity$16.9M+3.5%
Total assets$28.6M+5.1%

Cash flow

See full
Operating cash flow$14.7K+106%
CapEx$46.2K-89.6%
Free cash flow-$31.5K+95.4%

Valuation

See full
Market cap$206.24M+24.9%
Enterprise value$200.96M+25.1%
P/S4.8×+0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin-6%-2.3pp
Net margin-5.3%-2.1pp
FCF margin-37.1%+23.7pp

Returns & leverage

See full
Return on equity-13.7%-4.8pp
Debt / equity0.2×0.0×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by KORU Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireIntangibleAssets.

The official record: KORU Medical Systems’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about KORU Medical Systems's intangible purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is KORU Medical Systems's intangible purchases?
KORU Medical Systems (KRMD) reported intangible purchases of $43.72K in Q1 2026.
How has KORU Medical Systems's intangible purchases changed year-over-year?
KORU Medical Systems's intangible purchases increased by 1185.9% year-over-year, from $3.4K to $43.72K.
What is the long-term trend for KORU Medical Systems's intangible purchases?
Over 3 years (2021 to 2024), KORU Medical Systems's intangible purchases has grown at a 14.9% compound annual growth rate (CAGR), from $29.06K to $44.12K.
What does intangible purchases mean?
Cash spent acquiring intangible assets such as patents, licenses, and other intellectual property.